Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [49]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Research works printed but not linked: 1
- el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).
Cited by
Items 201–300 of 548
Witt, A. E., Hines, L. M., Collins, N. L., Hu, Y., Gunawardane, R. N., Moreira, D., Raphael, J., Jepson, D., Koundinya, M., Rolfs, A., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr050395r · Cited by 71
The Dachshund gene in development and hormone-responsive tumorigenesis
Popov, V. M., Wu, K., Zhou, J., Powell, M. J., Mardon, G., Wang, C., & Pestell, R. G. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.08.002 · Cited by 79
“(bicalutamide) may function as an antagonist in the absence of this co-repressor [42,43].”
BackgroundDDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response
Stoyanova, T., Roy, N., Kopanja, D., Raychaudhuri, P., & Bagchi, S. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10109 · Cited by 70
Tu, Y., Wu, W., Wu, T., Cao, Z., Wilkins, R. J., Toh, B. H., Cooper, M. E., & Chai, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609623200 · Cited by 73
Koga, H., Harada, M., Ohtsubo, M., Shishido, S., Kumemura, H., Hanada, S., Taniguchi, E., Yamashita, K., Kumashiro, R., Ueno, T., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50186 · Cited by 69
Human tumor suppressor p53 and DNA viruses
Collot‐Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 69
“The N-terminal domain of p21 interacts with and inhibits CDK-cyclin [41] halting phosphorylation of pRb protein so that E2F remains inactivated, bound to pRb (Figure 2).”
Archer, S. Y., Johnson, J. E., Kim, H., Ma, Q., Mou, H., Vishnuvardhan, D., Meng, S., & Hodin, R. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00575.2004 · Cited by 69
“With the use of the Qiagen Superfect transfection protocol (Qiagen; Valencia, CA), HT-29 cells were transiently transfected with pGL3-Basic plasmids containing various deletional constructs of the cB1 promoter from 1,050 to 64 bp upstream of the transcriptional start site with or without the p21 expression plasmid (Pf…”
BackgroundMethodLee, H. J., Wark, A. W., Goodrich, T. T., Fang, S., & Corn, R. M. (2005) · Langmuir · doi:10.1021/la046822h · Cited by 68
Yu, F. H. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2005 · Cited by 71
“The cdk and PCNA binding moieties of p21 are located separately (3, 17) and can be functionally separated by using truncated NH2-terminal or COOH-terminal domains (Fig.”
BackgroundMethodInfluentialChilosi, M., Doglioni, C., Magalini, A. R., Inghirami, G. G., Krampera, M., Nadali, G., Rahal, D., Pedron, S., Benedetti, A., Scardoni, M., et al. (1996) · Blood · doi:10.1182/blood.v88.10.4012.bloodjournal88104012 · Cited by 71
Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203000 · Cited by 76
“The sequestration of PCNA by p21 from the replication machinery proteins inhibits DNA replication (Flores-Rozas et al., 1994) and interferes with the interaction of PCNA with DNA methyltransferases (Chuang et al., 1997).”
BackgroundRosato, R. R., Almenara, J. A., Cartee, L., Betts, V., Chellappan, S., & Grant, S. (2002) · PubMed · Cited by 66
Shou, W., & Dunphy, W. G. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.457 · Cited by 68
Mutoh, M., Lung, F. ‐. T., Long, Y. Q., Roller, P. P., Sikorski, R. S., & O'Connor, P. M. (1999) · PubMed · doi:10.11501/3170955 · Cited by 72
Vernon, A. E., & Philpott, A. (2002) · Development · doi:10.1242/dev.00180 · Cited by 64
“The C terminus contains both a proliferating cell nuclear antigen (PCNA) binding region found in p21Cip1 (Waga et al., 1994; Chen et al., 1995) and a potential cdc2 phosphorylation site, the QT domain, shared with p27Kip1 and p57Kip2 (Polyak et al., 1994; Toyoshima and Hunter, 1994).”
Ruesch, M. N., & Laimins, L. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5570-5578.1997 · Cited by 54
“This increase in p21 protein levels results in a G1 arrest which is dependent on its association with cyclin-cdk complexes (7, 13, 46).”
BackgroundKriwacki, R. W., Wu, J., Siuzdak, G. E., & Wright, P. E. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960752m · Cited by 63
Taube, M. E., Liu, X.-W., Fridman, R. A., & Kim, H.-R. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209336 · Cited by 66
“…universal inhibitor of CDKs) and p16INK4a (an inhibitor of early G1 cyclin), TIMP-1 overexpression drastically enhanced the p27KIP1 levels, a potent CDKI of cell cycle progression from late G1 to the S phase (Toyoshima and Hunter, 1994; Chen et al., 1995; Luo et al., 1995; Sherr and Roberts, 1995).”
BackgroundChen, W. J., Chang, C.-Y., & Lin, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00156-4 · Cited by 62
Chow, L. T., & Broker, T. R. (1997) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00069-2 · Cited by 75
Protein kinases controlling the onset of mitosis
Ferrari, S. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5515-3 · Cited by 82
Bahl, R., Arora, S., Nath, N., Mathur, M., Shukla, N. K., & Ralhan, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203325 · Cited by 69
“…protein, with two protein binding domains, a N-terminal domain which binds and inhibits cyclinCdk complexes, and a short sequence near the Cterminus (between amino acid residues 144 ± 151) which binds to PCNA resulting in the inhibition of DNA replication (Xiong et al., 1993; Chen et al., 1995).”
BackgroundCell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle
Brian, T. Z. (2000) · Frontiers in bioscience · doi:10.2741/zafonte · Cited by 65
“The p21 family members have a conserved region near the amino terminus which is necessary and sufficient for binding to and inhibiting Cdk2 (68-70).”
BackgroundZhang, Y., Liu, Y., Duan, J., Yan, H., Zhang, J., Zhang, H., Fan, Q., Luo, F., Yan, G., Qiao, K., et al. (2015) · Hepatology · doi:10.1002/hep.28395 · Cited by 61
“Because HPCAL1 could regulate HCC cell growth by inhibiting G1/S transition, we next investigated whether HPCAL1 exerts its inhibitory function through modulation of p21, a potent regulator of cell cycle progression.((29)) The protein level of p21 Cip1 was measured when HPCAL1 was depleted or overexpressed.”
BackgroundChen, L., Li, J., Fan, Y., Qiu, J., Cao, L., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00458 · Cited by 65
Probing protein structure using biochemical and biophysical methods
Kriwacki, R. W., Wu, J., Tennant, L. L., Wright, P. E., & Siuzdak, G. E. (1997) · Journal of Chromatography A · doi:10.1016/s0021-9673(97)00527-x · Cited by 65
Cyclin-Dependent Kinase Inhibitors in Yeast, Animals, and Plants: A Functional Comparison
Clercq, A. D., & Inzé, D. (2006) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230600856685 · Cited by 75
Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours
Koopmann, J., Maintz, D. C., Schild, S. E., Schramm, J., Louis, D., Wiestler, O. D., & von Deimling, A. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.491 · Cited by 59
Yamato, K., Koseki, T., Ohguchi, M., Kizaki, M., Ikeda, Y., & Nishihara, T. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1044 · Cited by 60
Gibbs, E., Kelman, Z., Gulbis, J. M., O'Donnell, M., Kuriyan, J., Burgers, P. J., & Hurwitz, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2373 · Cited by 58
Simboeck, E., Sawicka, A., Zupkovitz, G., Senese, S., Winter, S., Dequiedt, F., Ogris, E., Di Croce, L., Chiocca, S., & Seiser, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184481 · Cited by 57
Xing, C., Xie, H., Zhou, L., Zhou, W., Zhang, W., Ding, S., Wei, B., Yu, X., Su, R., & Zheng, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.107 · Cited by 60
Guo, S., Presnell, S. R., Yuan, F., Zhang, Y., Gu, L., & Li, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313213200 · Cited by 57
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes
Engel, F. B., Hauck, L., Boehm, M., Nabel, E. G., Dietz, R., & von Harsdorf, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.555-565.2003 · Cited by 62
“and PCNA identified a small 20-amino-acid peptide derived from the C terminus of p21 that was sufficient to interact with PCNA and to inhibit SV40 DNA replication in vitro (10, 61).”
Backgroundp21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 62
Masih, P. J., Kunnev, D., & Melendy, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm943 · Cited by 56
“coli expression strain BL21 (DE3) (38).”
InfluentialHeinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4<428::aid-ijc5>3.0.co;2-2 · Cited by 70
Functional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbín, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F., Fueyo, A., & López-Otín, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
“…altered in the p21R94W mutant is consistent with results from different groups demonstrating that the CDK and PCNA inhibitory activities of p21 are functionally independent and reside in separate protein domains (Chen et al., 1995; Luo et al., 1995; Nakanishi et al., 1995; Warbrick et al., 1995).”
ResultBi, M., Yu, H., Huang, B., & Tang, C. (2017) · Gene · doi:10.1016/j.gene.2017.05.049 · Cited by 55
Determination of Helical Sense of Poly(N-propargylamides) by Exciton-Coupled Circular Dichroism
Tabei, J., Shiotsuki, M., Sanda, F., & Masuda, T. (2005) · Macromolecules · doi:10.1021/ma051884f · Cited by 54
Role for Cyclin A-dependent Kinase in DNA Replication in Human S Phase Cell Extracts
Fotedar, A., Cannella, D., FITZGERALD, P. J., Rousselle, T., Gupta, S., Dorée, M., & Fotedar, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31627 · Cited by 57
Cell cycle regulation: Repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_8.x · Cited by 59
Noya, F., Chien, W.-M., Broker, T. R., & Chow, L. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6121-6134.2001 · Cited by 43
“This result also indicates that cdk2 alone cannot stabilize p21cip1 protein in the absence of cyclin E despite its ability to interact with p21cip1 in vitro (6).”
BackgroundDong, Y., Yang, H. L., Elliott, M. J., & McMasters, K. M. (2002) · PubMed · Cited by 53
Wang, Z., Su, Z.-Z., Fisher, P. B., Wang, S., VanTuyle, G., & Grant, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4191 · Cited by 56
Incision-dependent and error-free repair of (CAG)n/(CTG)n hairpins in human cell extracts
Hou, C., Chan, N. L. S., Gu, L., & Li, G.-M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1638 · Cited by 52
“We performed repair assays in the presence of a purified p21 C-terminal peptide (p21C), which strongly inhibits PCNA functions in DNA replication and repai”
Signal Transduction in the Liver: C/Ebpβ Modulates Cell Proliferation and Survival
Buck, M., & Chojkier, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50155 · Cited by 57
Reed, W., Flørenes, V. A., Holm, R., Hannisdal, E., & Nesland, J. M. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050408 · Cited by 51
Involvement of the Multiple Tumor Suppressor Genes and 12-Lipoxygenase in Human Prostate Cancer
Gao, X., Porter, A. T., & Honn, K. V. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1813-0_7 · Cited by 51
Zhu, H., & Gooderham, N. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj146 · Cited by 54
“In addition, the ability of p21Cip1/WAF1 to interact with proliferating cell nuclear antigen (Chen et al., 1995; Luo et al., 1995), a protein functioning to provide replicative polymerases with the high processivity required to duplicate an entire genome (Johnson and O’Donnell, 2005; Majka and…”
BackgroundMomand, J., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3<343::aid-jcb1>3.0.co;2-v · Cited by 168
Complex Formation between Hepatitis C Virus Core Protein and p21Waf1/Cip1/Sdi1
Wang, F., Yoshida, I., Takamatsu, M., Ishido, S., Fujita, T., Oka, K., & Hotta, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2970 · Cited by 50
The Growth-Regulatory Role of p21 (WAF1/CIP1)
Gartel, A. L., & Tyner, A. L. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_4 · Cited by 57
Corroyer, S., Nabeyrat, E., & Clément, A. (1997) · Endocrinology · doi:10.1210/en.138.9.3677 · Cited by 53
Mechanism of Stimulation of Human DNA Ligase I by the Rad9-Rad1-Hus1 Checkpoint Complex
Wang, W., Lindsey-Boltz, L. A., Sancar, A., & Bambara, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602289200 · Cited by 49
Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity
Tarangelo, A., Rodencal, J., Kim, J. T., Magtanong, L., Long, J. Z., & Dixon, S. J. (2022) · Life Science Alliance · doi:10.26508/lsa.202101157 · Cited by 56
“In particular, we focused on thep21N-terminalcyclin-CDKbindingdomain, requiredfor inhibition of G1/S cell cycle progression, and the C-terminal PCNA binding domain involved in suppressing DNA synthesis (Chen et al, 1995) (Fig 2D).”
Lin, S.-Y., Lee, W.-R., Su, Y.-F., Hsu, S.-P., Lin, H.-C., Ho, P.-Y., Hou, T.-C., Chou, Y.-P., Kuo, C.-T., & Lee, W. (2012) · Angiogenesis · doi:10.1007/s10456-012-9289-6 · Cited by 49
Tomasevic, G., Kamme, F., Stubberöd, P., Wieloch, M., & Wieloch, T. W. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00484-9 · Cited by 52
Senescence and Apoptosis: Architects of Mammalian Development
Wanner, E., Thoppil, H., & Riabowol, K. T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620089 · Cited by 59
“…promote apoptosis through effects at the mitochondria of fibroblasts by interacting with Bax (Bose et al., 2013) and in melanoma cells in response to UV induced DNA damage, ING1 promoted p53-induced Bax expression to alter mitochondrial membrane potential and induce apoptosis (Cheung and Li, 2002).”
BackgroundWu, L. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-137 · Cited by 48
p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation
Bott, S., Arya, M., Kirby, R. S., & Williamson, M. P. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500822 · Cited by 48
P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells
Chang, F., & McCubrey, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204564 · Cited by 56
“They di er from the other Cdk inhibitor gene family INK4 in that they harbor both the Cdk and cyclin binding sites (Chen et al., 1995, 1996; Luo et al., 1995; Nakanishi et al., 1995; Lin et al., 1996).”
BackgroundProliferative lifespan checkpoints: Cell-type specificity and influence on tumour biology
Wynford‐Thomas, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00064-6 · Cited by 53
Brzuzan, P., Woźny, M., Ciesielski, S., Łuczyński, M. K., Góra, M., Kuźmiński, H., & Dobosz, S. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.03.032 · Cited by 51
Le, H.-V., Minn, A. J., & Massagué, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504689200 · Cited by 51
Effect of HIV-1 Vpr on Cell Cycle Regulators
Amini, S., Khalili, K., & Sawaya, B. E. (2004) · DNA and Cell Biology · doi:10.1089/104454904773819833 · Cited by 54
“The p21 WAF1 protein contains discrete cyclin-and CDK-binding domains, which are present mainly in the N-terminal region, whereas a PCNA-binding domain is present in a C-terminal region (Chen et al. , 1995).”
Mukhopadhyay, U. K., Senderowicz, A. M., & Ferbeyre, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2502 · Cited by 47
“For example, p21 is a major PCNA inhibitor (42); thus, cells disabled for both p53 and the ATM/ATR checkpoint pathways may have a synergistic increase in PCNA activity.”
BackgroundCell cycle regulation: repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00087-1 · Cited by 45
Retroviral Delivery of Peptide Modulators of Cellular Functions
Lorens, J. B., Bennett, M. K., Pearsall, D., Throndset, W., Rossi, A. B., Armstrong, R. J., Fox, B., Chan, E., Luo, Y., Masuda, E. S., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0063 · Cited by 48
Ralhan, R., Agarwal, S., Mathur, M., Wasylyk, B., & Srivastava, A. (2000) · PubMed · Cited by 47
Kim, Y. J., Chung, J., Lee, S. G., Kim, D. Y., Park, J.-E., Kim, W. R., Joo, B. S., Han, S.-H., Yoo, K. S., Yoo, Y. H., et al. (2011) · Toxicology · doi:10.1016/j.tox.2011.04.013 · Cited by 47
Schepers, H., Geugien, M., Eggen, B. J. L., & Vellenga, E. (2003) · Leukemia · doi:10.1038/sj.leu.2403106 · Cited by 46
Park, J. S., Carter, S., Reardon, D. B., Schmidt‐Ullrich, R., Dent, P., & Fisher, P. B. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.12.4231 · Cited by 46
“Several groups have argued that p21 may function both as a cyclin kinase inhibitor protein and as a scaffold protein (Chen et al., 1995, 1996; Morgan, 1995; Sherr and Roberts, 1995).”
BackgroundExpression and Role of p53 in the Retina
Vuong, L., Conley, S. M., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8909 · Cited by 51
“In vitro work has shown that p21 can interfere with PCNA interaction with replication factor C, DNA polymerase , and flap endonuclease 1, resulting in a p21mediated blockage of DNA replication and repair.(43)”
Lu, D., Han, C. Q., & Wu, T. (2013) · Oncogene · doi:10.1038/onc.2013.69 · Cited by 45
“The growth-inhibitory action of p21 is attributed to the functions of the carboxy-terminal PCNA-binding domain as well as the amino-terminal CDK-cyclin inhibitory domain(41, 42).”
BackgroundKeller, C., & Krude, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003073200 · Cited by 52
Korkolopoulou, P. A., Kouzelis, K., Christodoulou, P. N., Papanikolaou, A., & Thomas-Tsagli, E. (1998) · Acta Neuropathologica · doi:10.1007/s004010050848 · Cited by 45
“To examine the impact on an altered pRb expression we divided our cases into two groups: those with a normal or increased pRb/Ki-67 ratio and those with a diminished pRb/Ki-67 ratio [ 3 ].”
BackgroundRodríguez-Vilarrupla, A., Jaumot, M., Abella, N., Canela-Canela, N., Brun, S., Díaz, C., Estanyol, J. M., Bachs, O., & Agell, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7364-7374.2005 · Cited by 44
“Like other members of the CIP/KIP family, p21 contains conserved cyclin and cdk-binding domains near the amino terminus of the molecule (10, 20, 21, 34, 39).”
BackgroundYao, J., Duan, L., Fan, M., Yuan, J., & Wu, X. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9332-2 · Cited by 44
“P21WAF1/CIP can also directly inhibit DNA synthesis by binding to proliferating cell nuclear antigen (PCNA) [28].”
BackgroundKoike, M., Elstner, E., Campbell, M. J., Asou, H., Uskoković, M. R., Tsuruoka, N., & Koeffler, H. (1997) · PubMed · Cited by 46
Huang, Y., Zhu, Y., Yang, J., Pan, Q., Zhao, J., Song, M., Yang, C., Han, Y., Tang, Y., Wang, Q., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04676-1 · Cited by 45
“In addition, by binding to proliferating cell nuclear antigen (PCNA), p21 interferes with PCNA-dependent DNA polymerase activity, which is required for DNA replication and repair processes [19, 20].”
BackgroundSustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition
Ritt, M. G., Mayor, J., Wojcieszyn, J. W., Smith, R., Barton, C. L., & Modiano, J. F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00507-3 · Cited by 44
“This protein has multifactorial functions, including facilitating the assembly of cyclin-dependent kinase (Cdk) holoenzyme complexes [7], and modulating the activity of Cdks [8±11], stress-activated protein kinases [12], and the proliferating cell nuclear antigen, PCNA [13,14].”
BackgroundHsiao, M., Tse, V., Carmel, J. B., Costanzi, E., Strauss, B. E., Haas, M., & Silverberg, G. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6450 · Cited by 44
Meiotic cell cycle in Xenopus oocytes is independent of cdk2 kinase
Furuno, N., Ogawa, Y., Iwashita, J., Nakajo, N., & Sagata, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3860 · Cited by 42
“…endogenous proteins,with either neutralizing anti-Mos antibody (Furuno et al., 1994) or control rabbit IgG, and harvested them 1.5 and such as cdk4 kinase and PCNA (Elledge and Harper, 1994; Chen et al., 1995), that might be present in maturing3 h later to measure MPF and cdk2 kinase activities.”
BackgroundInfluentialAutocatalytic Phosphorylation of CDK2 at the Activating Thr160
Abbas, T., Jha, S., Sherman, N. E., & Dutta, A. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4000 · Cited by 45
Self-citationDownregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia
Gehen, S. C., Vitiello, P. F., Bambara, R. A., Keng, P. C., & O’Reilly, M. A. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00135.2006 · Cited by 44
“Through its unique carboxy-terminal domain, p21 binds to proliferating cell nuclear antigen (PCNA) and inhibits its function as a DNA polymerase processivity factor (7, 12).”
Backgroundp21 WAF1 Mutations and human malignancies
Shiohara, M., Koike, K., Komiyama, A., & Koeffler, H. P. (1997) · Leukemia & Lymphoma · doi:10.3109/10428199709109155 · Cited by 41
Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development
Palmer, N., & Kaldis, P. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.05.001 · Cited by 41
Zhang, Q., Wang, J., Fan, S., Wang, L., Cao, L., Tang, K., Peng, C., Li, Z., Li, W., Gan, K., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.058 · Cited by 39
“One of these is the cyclin-CDK family of kinases and the other is the essential DNA replication factor, PCNA [42–45].”
BackgroundNerve Growth Factor-induced Growth Arrest and Induction of p21 in NIH-3T3 Cells Expressing TrkA
Decker, S. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30841 · Cited by 44
Soto, D. R., Barton, C., Munger, K., & McLaughlin-Drubin, M. E. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 39
“In contrast, ectopic expression of the carboxyl terminal p21 domain, which contains the PCNA binding site and is sufficient to inhibit PCNA [42], efficiently rescued the decrease in viability upon KDM6A depletion.”
BackgroundLI, T., XUE, H., Guo, Y., & Guo, K. (2014) · Oncology Reports · doi:10.3892/or.2014.3045 · Cited by 39
Hughes, J., Brown, P. A., & Shankland, S. J. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f948 · Cited by 39
“Unlike p27 or p57, p21 has the additional function of binding and inhibiting the proliferating cell nuclear antigen (PCNA), which plays an important role in both DNA replication and DNA repair (5, 6, 24).”
BackgroundShi, Y., Zou, M., Farid, N., & Al‐Sedairy, S. T. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.546 · Cited by 44
A Novel Role of RASSF9 in Maintaining Epidermal Homeostasis
Lee, C.-M., Yang, P., Chen, L., Chen, C., Wu, S., Cheng, H.-Y., & Chang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017867 · Cited by 40
“replication by associating with cyclin-CDK and binding to PCNA via two distinct functional domains [28,29].”
BackgroundLi, Y., Liu, J., & Li, Q. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20623 · Cited by 42
“addition to the ability to bind and inhibit cyclin/ CDK complexes, p21/WAF1 also has the ability to interact with PCNA [50,51] and inhibit stressactivated protein kinases [52].”
BackgroundTrautwein, C., Will, M., Kubicka, S., Rakemann, T., Flemming, P., & Manns, M. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203045 · Cited by 38
“…which is transcriptionally controlled through p53 binding sites in its promoter region (el Deiry et al., 1994). p21 is a member of the CKI family (Sherr and Roberts, 1995) and interacts with cyclin A/CdK2, cyclin D/CdK4/6 and cyclin E/CdK2 complexes (Harper et al., 1995; Chen et al., 1995).”
BackgroundActivation of the p21Waf1/Cip1Promoter by theetsOncogene Family Transcription Factor E1AF
Funaoka, K., Shindoh, M., Yoshida, K., HANZAWA, M., Hida, K., NISHIKATA, S., Totsuka, Y., & Fujinaga, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6909 · Cited by 43
Regulation of replication fork speed: Mechanisms and impact on genomic stability
Merchut‐Maya, J. M., Bártek, J., & Maya‐Mendoza, A. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102654 · Cited by 39
Inhibition of p53-Mediated Growth Arrest by Overexpression of Cyclin-Dependent Kinases
Latham, K. M., Eastman, S. W., Wong, A., & Hinds, P. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4445 · Cited by 36
“For example, p21 may inhibit replication because of its association with proliferating-cell nuclear antigen (5, 84); this association may also be reduced in cdk4- and cdk6-rescued A1-5 cells.”
Background
Metadata
- Authors
- Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Nature
- Published
- 1995-03
- Volume
- 374
- Issue
- 6520
- Pages
- 386-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078690152
- Cited by
- 548
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 20
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, WAF1/CIP1, p53, PCNA, proliferating cell nuclear antigen, protein domains, N-terminal domain, C-terminal domain, DNA replication inhibition, cell cycle arrest, growth inhibition, tumour suppressor
- MeSH terms
- Animals, Haplorhini, Binding Sites, Cell Division, Cell Line, Transformed, DNA Replication, Escherichia coli, Humans, Peptide Fragments, Recombinant Fusion Proteins, Simian virus 40, Tumor Cells, Cultured, Xenopus, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Xenopus Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.